BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Breast cancer AND MLH1, COCA2, 4292, ENSG00000076242, hMLH1, FCC2, HNPCC2, P40692, MGC5172, HNPCC AND Clinical Outcome
5 results:

  • 1. Quantitative DNA methylation analyses reveal stage dependent DNA methylation and association to clinico-pathological factors in breast tumors.
    Klajic J; Fleischer T; Dejeux E; Edvardsen H; Warnberg F; Bukholm I; Lønning PE; Solvang H; Børresen-Dale AL; Tost J; Kristensen VN
    BMC Cancer; 2013 Oct; 13():456. PubMed ID: 24093668
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Discovery of colorectal cancer PIK3CA mutation as potential predictive biomarker: power and promise of molecular pathological epidemiology.
    Ogino S; Lochhead P; Giovannucci E; Meyerhardt JA; Fuchs CS; Chan AT
    Oncogene; 2014 Jun; 33(23):2949-55. PubMed ID: 23792451
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Clinicopathological and molecular characterization of colorectal micropapillary carcinoma.
    Verdú M; Román R; Calvo M; Rodón N; García B; González M; Vidal A; Puig X
    Mod Pathol; 2011 May; 24(5):729-38. PubMed ID: 21336262
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Hereditary ovarian cancer.
    Prat J; Ribé A; Gallardo A
    Hum Pathol; 2005 Aug; 36(8):861-70. PubMed ID: 16112002
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Hereditary risk of women's cancers.
    Frank TS; Critchfield GC
    Best Pract Res Clin Obstet Gynaecol; 2002 Oct; 16(5):703-13. PubMed ID: 12475549
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.